Jesse I. Treu, 10% Owner at CADENCE PHARMACEUTICALS INC (CADX), sold 591 shares at $5.32 ($3K) on 2013-03-08, disclosed to the SEC on 2013-03-11.
Scheduled sale ($3k) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.22 | 420 | $2K | 70.7% |
| 2 | $5.32 | 171 | $910 | 29.3% |
| Total | $5.25 avg | 591 | $3K | 100% |
| Filing → |
| OBLN | BUY | 2018-08-27 | $6.0M | — | Filing → |
| VCYT | SELL | 2018-08-02 | $10.8M | — | Filing → |
| VCYT | SELL | 2017-05-18 | $18K | — | Filing → |